1976
DOI: 10.1016/s0076-6879(76)45024-3
|View full text |Cite
|
Sign up to set email alerts
|

[21] Streptokinase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
47
0

Year Published

1990
1990
2011
2011

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 93 publications
(47 citation statements)
references
References 20 publications
0
47
0
Order By: Relevance
“…The majority of GAS strains that cause human diseases secrete a plasminogen activator, streptokinase (Ska). The latter forms a 1:1 stoichiometric complex with plasminogen, converts other plasminogen molecules into active plasmin, and is not regulated by host fluid phase ␣ 2 -antiplasmin (Apl) (10).…”
mentioning
confidence: 99%
“…The majority of GAS strains that cause human diseases secrete a plasminogen activator, streptokinase (Ska). The latter forms a 1:1 stoichiometric complex with plasminogen, converts other plasminogen molecules into active plasmin, and is not regulated by host fluid phase ␣ 2 -antiplasmin (Apl) (10).…”
mentioning
confidence: 99%
“…Notably, these bacterial activators can modify the specificity of the bound host proteinase toward macromolecular substrates by providing novel docking sites for substrate recognition (8). The mechanism of nonproteolytic, cofactor-induced activation has been intensively investigated for streptokinase (SK), a Pg activator secreted by ␤-hemolytic streptococci (9,10), as well as for staphylocoagulase (SC), a prothrombin (ProT) activator from Staphylococcus aureus (11)(12)(13). Another Pg activator from S. aureus, staphylokinase, is structurally related to SK (8,14) but requires active plasmin (Pm) to form an activator complex of free Pg molecules (15,16).…”
mentioning
confidence: 99%
“…Streptokinase (STK), a protein of 415 amino acids that does not contain disulfide bridges, is produced and excreted by some strains of ß-hemolytic streptococci (1,2). Because of its ability to activate the fibrinolytic system, it is currently used as a thrombolytic agent for the treatment of patients with acute myocardial infarction (3,4).…”
mentioning
confidence: 99%